Register Cart 0

Generic placeholder image

Current Drug Targets

Editor-in-Chief

ISSN (Print): 1389-4501
ISSN (Online): 1873-5592

Back Subscribe

Novel Tyrosine Kinase Inhibitors in the Treatment of Cancer

Author(s): Alberto Ocana, Rosario Serrano, Raul Calero and Atanasio Pandiella

Volume 10, Issue 6, 2009

Page: [575 - 576] Pages: 2

DOI: 10.2174/138945009788488378

Price: $65

Abstract

Full text available

« Previous Next »

Rights & Permissions Print Cite

Article Metrics

4

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

Related Articles

Cancer Neovascularization and Proinflammatory Microenvironments
Current Cancer Drug Targets

Role of Infection Control in Prevention of Hepatitis B virus (HBV) in Hemodialysis (HD) Patients.
Infectious Disorders - Drug Targets

Natural History of the Nihon Rat Model of BHD
Current Molecular Medicine

The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Current Cancer Drug Targets

Compounds that Combine Aldose Reductase Inhibitory Activity and Ability to Prevent the Glycation (Glucation and/or Fructation) of Proteins as Putative Pharmacotherapeutic Agents
Drug Design Reviews - Online (Discontinued)

Sorafenib (BAY 43-9006) in Hepatocellular Carcinoma Patients: From Discovery to Clinical Development
Current Medicinal Chemistry

Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report
Current Drug Targets

Nano Approaches to Enhance Pharmacokinetic and Pharmacodynamic Activity of Plant Origin Drugs
Current Nanoscience

Adverse Drug Reactions in the Oral Cavity
Current Pharmaceutical Design

Pharmacological Strategies to Overcome HER2 Cross-Talk and Trastuzumab Resistance
Current Medicinal Chemistry

Styrene Maleic Acid Neocarzinostatin Treatment for Hepatocellular Carcinoma
Current Medicinal Chemistry - Anti-Cancer Agents

Pharmacophore Generation and 3D-QSAR of Novel 2-(quinazolin-4- ylamino)-[1,4] Benzoquinone Derivatives as VEGFR-2 Inhibitors
Letters in Drug Design & Discovery

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies
Current Cancer Drug Targets

Learning from Metabolic Networks: Current Trends and Future Directions for Precision Medicine
Current Medicinal Chemistry

Mikuliczs Disease and its Extraglandular Lesions
Current Immunology Reviews (Discontinued)

Angiogenesis as a therapeutic target in breast cancer
Mini-Reviews in Medicinal Chemistry

Diallyl Sulfide: Potential Use in Novel Therapeutic Interventions in Alcohol, Drugs, and Disease Mediated Cellular Toxicity by Targeting Cytochrome P450 2E1
Current Drug Metabolism

Cancer-associated Autoantibodies as Biomarkers for Early Detection and Prognosis is Cancer: An Update
Current Cancer Therapy Reviews

Conjugative Post-Translational Modifications for Pharmacological Improvement of Therapeutic Proteins
Current Proteomics

From the Sea to Anticancer Therapy
Current Medicinal Chemistry

© 2025 Bentham Science Publishers | Privacy Policy